drugset / Trial / NCT00218049

Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals

NCT00218049 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to determine the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.

Timeline

Start
2004-12
Primary completion
2005-07
Completion
2005-07

Outcome

Outcome not reported

Stopped: “Issue of priority of resources”

Drugs

EvaluationDrugModalityDoseRoute
Subject vanoxerine Small molecule 50 mg —
Subject vanoxerine Small molecule 75 mg —
Subject vanoxerine Small molecule 100 mg —